An active antibody fragment (Fv) composed of the variable portions of heavy and light chains.
about
Amino acid sequence of the Fv region of a human monoclonal IgM (protein WEA) with antibody activity against 3,4-pyruvylated galactose in Klebsiella polysaccharides K30 and K33Production of BALB/c anti-idiotypic antibodies against the BALB/c myeloma protein 315 does not require an intact ligand-binding siteThe combining site of the dinitrophenyl-binding immunoglobulin A myeloma protein MOPC 315Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coliEvolving concepts of specificity in immune reactionsA small hypervariable segment in the variable domain of an immunoglobulin light chain stimulates formation of anti-idiotypic suppressor T cells.Immunological probes in cardiovascular disease.Metal-binding chimeric antibodies expressed in Escherichia coli.A functional examination of hapten-binding derivatives from a murine myeloma protein with immunoglobulin features.Inhibition of immunoglobulin folding and secretion by dominant negative BiP ATPase mutants.Cold pepsin digestion: a novel method to produce the Fv fragment from human immunoglobulin M.Use of deuterium labelling in NMR studies of antibody combining site structure.Immunotoxicotherapy: present status and future trends.Interactions of the lanthanide- and hapten-binding sites in the Fv fragment from the myeloma protein MOPC 315.T helper lymphocytes recognize the VL domain of the isologous mouse myeloma protein 315.The gross architecture of an antibody-combining site as determined by spin-label mapping.Structure and function of the constant regions of immunoglobulins.Production of antibody fragments in Escherichia coli.Inhibitors of renin: present and future.Recognition of the self idiotype by T cells: induction of a rapid increase in cytoplasmic free calcium in T cells recognizing a variable L chain determinant.Crystallization of the Fv fragment of mouse myeloma protein M315The role of nitro groups in the binding of nitroaromatics to protein MOPC 315.The specificity of chain interactions among immunoglobulins. Combinations of gamma chains with kappa chains of the same subgroup as in the parent immunoglobulin G.Expression, purification and characterization of B72.3 Fv fragments.Two M315 idiotopes defined by isologous monoclonal antibodies: one depends on germline and the other on mutated murine lambda 2 light chain sequences.Helper T cell recognition of the variable domains of a mouse myeloma protein (315). Effect of the major histocompatibility complex and domain conformation.T helper cells recognize an idiotope located on peptide 88-114/117 of the light chain variable domain of an isologous myeloma protein (315).Mono- and bivalent antibody fragments produced in Escherichia coli: engineering, folding and antigen binding.Recombinant single-chain antibodies with various oligopeptide tails for targeted gene delivery.Idiotypical identity of IgG myeloma protein with monoclonal IgM, Bence Jones protein, and Fv derived from one patient.Cloning and expression of an HIV-1 specific single-chain Fv region fused to Escherichia coli alkaline phosphatase.
P2860
Q28116465-E8CB6B44-1731-4E13-B1D0-187DEA739508Q28318109-0CDCC862-3B90-45B0-908C-2DE9B08F5A48Q28333310-C061BF41-DB5F-45E4-B1A8-23604119FE83Q33638891-2A7F7EF2-8D6D-451C-9F72-D016D83AFDF1Q34450109-F6DA4B5A-ABD8-493F-8A62-0C5485AA4A7BQ36311069-F2EE07F3-7C9A-4889-B889-5EB2FD65E267Q36737262-DFAF6667-2F88-405F-BC36-55BF943FF017Q37252448-3F04FB69-A81F-46F1-BCAE-5C406355DEF0Q37444610-DE347190-9A3A-4EFE-B4C8-C6D7D5482D5BQ37581998-6DB385D0-0EA0-4E18-A16F-BA6D7AA205EBQ37588017-BD959CEE-FA89-4F4C-8B9C-C190D286E55EQ37924787-80F6DC33-82DA-4894-A4B4-AF187B188DF0Q38682222-49C4A933-D737-47EB-8491-2342FBEF5E49Q39102001-F0E352D4-E951-46B3-9D7C-B54B19813AC8Q39586202-CEB42D3E-5E87-452B-ACAE-F23540474AD4Q40110194-897D5040-68EF-4F16-B833-24CA2988C477Q40592061-44C0D2B0-D554-441D-AAB2-C1DB46980A53Q41003887-F8B28DFE-8C16-4D29-8C10-2C8FC575359BQ41452341-CD0C709C-BA02-4A93-8DBF-058C111DBE63Q41649767-E8D01B81-5453-485A-B1DA-692D642A8E8CQ41855265-E225560B-2D4D-40CF-A0DF-18403E51A6F1Q42011309-BE7FEF9D-4AA5-42C7-B6C8-75B13D21E113Q42562022-5F3E203A-7686-4C3E-8017-9634ACB60328Q42599847-D8DD30B9-1CA4-4AC4-BE0D-E9731EFD0B59Q42800591-7B30C833-029D-41D6-AC11-26785768775DQ42936166-8026DCEB-0C17-481D-BBC9-A2CAE00B62AAQ42936713-4FB72B33-E8E4-4D11-BF05-0045843FFC04Q43709906-9690E3B3-A5D1-4028-9FB6-4559A9A43CE7Q44409501-66F9C588-91BA-4DC2-A08C-99405C08997DQ44473455-A9D57302-CF63-4CF4-928D-5D6B47D7B0ADQ45130884-39E2C6E0-D8D1-4D43-A850-F2E713C9E30C
P2860
An active antibody fragment (Fv) composed of the variable portions of heavy and light chains.
description
1973 nî lūn-bûn
@nan
1973 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1973 թվականի մարտին հրատարակված գիտական հոդված
@hy
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
name
An active antibody fragment (F ...... ons of heavy and light chains.
@ast
An active antibody fragment (F ...... ons of heavy and light chains.
@en
An active antibody fragment
@nl
type
label
An active antibody fragment (F ...... ons of heavy and light chains.
@ast
An active antibody fragment (F ...... ons of heavy and light chains.
@en
An active antibody fragment
@nl
prefLabel
An active antibody fragment (F ...... ons of heavy and light chains.
@ast
An active antibody fragment (F ...... ons of heavy and light chains.
@en
An active antibody fragment
@nl
P2093
P356
P1433
P1476
An active antibody fragment (F ...... ons of heavy and light chains.
@en
P2093
P304
P356
10.1021/BI00730A018
P407
P577
1973-03-01T00:00:00Z